ID
39868
Descripción
Study ID: 110399 Clinical Study ID: 110399 Study Title: A randomized, double blind, parallel group, placebo controlled 28 day study to investigate the safety, tolerability and pharmacodynamics of SB-656933 in subjects with cystic fibrosis. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00903201 https://clinicaltrials.gov/ct2/show/NCT00903201?term=NCT00903201 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB656933, Placebo Trade Name: N/A Study Indication: Cystic Fibrosis The study consists of a screening, five study visits and a follow-up (time relative to Baseline in days): Visit 1: Screening, Day -28 to -16 Visit 2a: Day -7 to -4 Visit 2b: Day 1 Visit 3: Day 14 Visit 4: Day 21 Visit 5: Day 28 Visit 6: Early Withdrawal/ Follow-up, Day 35 to 42. From day 1 to day 28 the patients will receive daily doses. This document contains the concomitant medication form. It has to be filled in if concomitant medication has been taken by subject during the study.
Link
https://clinicaltrials.gov/ct2/show/NCT00903201?term=NCT00903201
Palabras clave
Versiones (2)
- 25/2/20 25/2/20 -
- 4/3/20 4/3/20 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
25 de febrero de 2020
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Safety, tolerability and pharmacodynamics of Elubrixin in cystic fibrosis patients, NCT00903201
Concomitant medication
- StudyEvent: ODM
Descripción
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Descripción
Sequence Number
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C2348184
Descripción
(Trade Name preferred)
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2360065
- UMLS CUI [1,2]
- C2347852
Descripción
In the original form this item is hidden.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826819
Descripción
In the original form this item is hidden.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0871468
Descripción
In the original form this item is hidden.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C1516698
- UMLS CUI [1,3]
- C0805701
Descripción
In the original form this item is hidden.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0805701
- UMLS CUI [1,2]
- C0231175
Descripción
Unit Dose
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826646
Descripción
Units of concomitant medication
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0439148
Descripción
Frequency of concomitant medication
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826654
Descripción
Route of concomitant medication
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826730
Descripción
Reason for Medication
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826696
Descripción
day month year
Tipo de datos
partialDate
Alias
- UMLS CUI [1]
- C2826734
Descripción
00:00-23:59
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C1301880
Descripción
Concomitant medication prior to study
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826667
Descripción
If you tick No, please specify End date and time in the appropriate items.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826666
Descripción
day month year
Tipo de datos
partialDate
Alias
- UMLS CUI [1]
- C2826744
Descripción
00:00-23:59
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C1522314
- UMLS CUI [1,2]
- C2347852
Similar models
Concomitant medication
- StudyEvent: ODM
C2347852 (UMLS CUI [1,2])
C0871468 (UMLS CUI [1,2])
C1516698 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,2])
C0439148 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
Sin comentarios